With the launch of the Dextrometer in 1980, blood glucose self-monitoring became the standard of care for patients with diabetes.1 Since then, advancements in diabetes technologies have increased rapidly, much like the prevalence of the condition itself.
Today, a plethora of diabetes technologies are available to patients with diabetes, with innovations continuously rolling out. Just last year, the FDA cleared the first-ever do-it-yourself automated insulin delivery system.2 Even more recently, the agency approved 2 new OTC continuous glucose monitors (CGMs).3
Underscoring the progress in the industry, 4 abstracts presented at the American Diabetes Association 84th Scientific Sessions, held June 21 to 24 in Orlando, Florida, investigated the impact of various new diabetes technologies on managing the condition.
Click here for more of our coverage from ADA 2024.
READ MORE: Diabetes Resource Center
Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
References
1. Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83-93.
2. Briskin A. Tidepool expands closed loop access, wins clearance from FDA. diaTribe. January 26, 2023. https://diatribe.org/diabetes-technology/tidepool-expands-closed-loop-access-wins-clearance-fda
3. Meara K. FDA approves 2 new OTC continuous glucose monitors. Drug Topics. June 11, 2024. https://www.drugtopics.com/view/fda-approves-2-new-otc-continuous-glucose-monitors
4. Thorsell AA, Bevier WC, Castorino KN, et al. Acceptability and impact of a Spanish-language diabetes management smartphone application (mySugr PRO) in Hispanic/Latino adults with uncontrolled type 2 diabetes. Presented at: American Diabetes Association 84th Scientific Sessions; June 21-24, 2024; Orlando, FL. Abstract 1015-P.
5. Tillman J, Olson BP, Malone JK. Real-world experience with Bigfoot Unity—a twelve-month retrospective analysis. Presented at: American Diabetes Association 84th Scientific Sessions; June 21-24, 2024; Orlando, FL. Abstract 1008-P.
6. Pellizzari M, Nwosu BU, Pavlovic M, Talib R, Sohail R, Ciron J. The safety and efficacy of virtual insulin pump initiation in children and adolescents with type 1 diabetes in the United States. Presented at: American Diabetes Association 84th Scientific Sessions; June 21-24, 2024; Orlando, FL. Abstract 134-OR.
7. Kudva YC, Henderson R, Kanapka L, et al. A randomized clinical trial of automated insulin delivery in elderly with type 1 diabetes. Presented at: American Diabetes Association 84th Scientific Sessions; June 21-24, 2024; Orlando, FL. Abstract 144-OR.
